Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1Phase 1 1

Status

Completed 4

Sponsor Class

OTHER 7INDUSTRY 4NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1

Conditions

Chemotherapy Induced Neutropenia 2Prostatic Neoplasms 1Lymphoma 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 313atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × pegylated granulocyte colony-stimulating factor, human × Clear all
NCT02963389 2019-01-15

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients

Dong-A ST Co., Ltd.

Phase 1 Completed
27 enrolled
Lymphoid

Lymphoma

NCT02441894 2017-01-24

PEGAZUS

Sanofi

Phase 4 Completed
21 enrolled
Genitourinary

Prostatic Neoplasms

NCT01674855 2014-10-01

PEG-G-CSF

Dong-A ST Co., Ltd.

Phase 3 Completed
74 enrolled

Chemotherapy Induced Neutropenia

NCT01923545 2014-10-01

PEG-G-CSF

Dong-A ST Co., Ltd.

Phase 2 Completed
61 enrolled

Chemotherapy Induced Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡